Table III.
LAPTM4B genotype | ||||
---|---|---|---|---|
Characteristics | 1/1 | 1/2 | 2/2 | P-value |
Age, years | 0.705 | |||
>40 | 50 | 37 | 12 | |
≤40 | 40 | 36 | 8 | |
Sex | 0.046 | |||
Female | 64 | 49 | 19 | |
Male | 26 | 24 | 1 | |
CLNM | 0.219 | |||
Positive | 56 | 53 | 11 | |
Negative | 34 | 20 | 9 | |
Invasive tumor | 0.531 | |||
Yes | 49 | 39 | 8 | |
No | 41 | 34 | 12 | |
Tumor size, cm | 0.836 | |||
≥1 | 40 | 26 | 8 | |
<1 | 46 | 42 | 11 | |
Unknown | 4 | 5 | 1 | |
TNM stage | 0.290 | |||
I–II | 58 | 41 | 10 | |
III–IV | 19 | 16 | 8 | |
Unknown | 13 | 16 | 2 | |
Tumor location | 0.777 | |||
One side | 17 | 8 | 4 | |
Two sides | 1 | 3 | 0 | |
Isthmus | 3 | 2 | 1 | |
Two sides and isthmus | 7 | 7 | 1 | |
One side and isthmus | 62 | 53 | 14 | |
BMI | 0.531 | |||
>25 | 49 | 39 | 8 | |
≤25 | 41 | 34 | 12 |
LAPTM4B, lysosome-associated protein transmembrane 4-β; CLNM, central lymph node metastasis; TNM, tumor-node-metastasis.